Global patient access Accell Clinical Research offers guaranteed fast patient recruitment across 20+ countries in Europe and the CIS, presenting a sales opportunity to expand sponsor networks seeking efficient enrollment in Phase I-III trials.

Full-service CRO With end-to-end capabilities from feasibility and regulatory support to data management and safety management, target sponsors looking to consolidate outsourcing to a single partner for Phase I-III studies.

Therapeutic breadth Specialization across oncology, cardiovascular, immunology, gastroenterology, neurology, and endocrinology suggests cross-sell potential to sponsors with multiple trial needs or upcoming studies in these areas.

Regional clinical footprint Local medical staff and regional legal entities in Europe and CIS can appeal to sponsors requiring local site access, regulatory familiarity, and efficient multi-country execution with compliant operations.

SME agility advantage Smaller organization size (11-50 employees) paired with a broad service scope can attract mid-market sponsors seeking personalized, flexible engagement models and tighter project management.